Metric Finance
LearnFAQ
LearnFAQ

Learn / RLX

NYSE: RLX

RLX Technology (RLX) stock, explained like you're 5

RLX Technology trades on the New York Stock Exchange under the ticker RLX. It is a mid cap company in the medicinal chemicals and botanical products industry, part of the healthcare sector, with a market value of about 2.1 billion dollars.

Ticker
RLX
Exchange
New York Stock Exchange
Sector
Healthcare
Industry
Medicinal Chemicals and Botanical Products
Size
Mid cap, about 2.1 billion dollars

Is RLX Technology a small, medium or large cap company?

No. RLX Technology is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How RLX Technology makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves RLX stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Why RLX Technology Bears Were Right Before The Drop (Simply Wall Street)
  • RLX Technology Q2 Earnings Call Highlights (Yahoo Finance)
  • RLX Finviz (Finviz)
  • RLX Technology: Focus On The Fundamentals (NYSE:RLX) (Seeking Alpha)
  • RLX Technology (RLX) Stock Sinks On Second Half Margin Warning (Simply Wall Street)

Follow RLX in your daily brief

Each trading day at 5 PM ET we post what happened to RLX Technology and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow RLX

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about RLX Technology stock

What does RLX Technology do?

RLX Technology trades on the New York Stock Exchange under the ticker RLX. It is a mid cap company in the medicinal chemicals and botanical products industry, part of the healthcare sector, with a market value of about 2.1 billion dollars.

What is the ticker symbol for RLX Technology?

RLX Technology trades under the ticker RLX on the New York Stock Exchange.

What is RLX Technology's market cap?

RLX Technology is a mid cap stock with a market cap of about 2.1 billion dollars.

How does RLX Technology make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves RLX stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow RLX stock every day?

Add RLX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow RLX daily

A free brief on RLX Technology and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • BTI · British American Tobacco p.l.c.
  • DFTX · Definium Therapeutics
  • RGC · Regencell Bioscience Holdings Ltd
  • TRLV · Trulieve Cannabis

Similar stocks

  • BTIBritish American Tobacco p.l.c.
  • DFTXDefinium Therapeutics
  • RGCRegencell Bioscience Holdings Ltd
  • TRLVTrulieve Cannabis

Compare RLX: RLX vs BTI, RLX vs DFTX, RLX vs RGC

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed